The Next Generation Biotech Media
In recent times, several big pharma have collaborated with small companies in the immuno-oncology field. Last September, Pfizer made a $200 million investment to collaborate with CStone Pharmaceuticals. Now Novartis …
Read More
By Judy Ya-Hsuan Lin Cancerous tumors create highly specific conditions in their growth environment that are not present in normal tissues. Their established specificity allows researchers to develop safer therapeutic …
Read More
On April 13th, the immuno-oncology company announced that its PD-1 monoclonal antibody, tislelizumab in combination with chemotherapy, extended progression free survival in patients with first-line non-squamous, Non-Small Cell Lung Cancer …
Read More
20191230-20200105 The 4th Asia Microbiome Conference The human gut hosts a vast array of microbes collectively known as the microbiota, or intestinal flora. It is believed to play an important …
Read More
By Rajaneesh K. Gopinath, Ph.D. The 2019 Asian edition of the European Society for Medical Oncology Congress (ESMO Asia) brought together more than 3,500 medical professionals from the Asia Pacific …
Read More
20191110-1116 I-Mab Biopharma Receives IND Approval from NMPA to Initiate Clinical Trials for its Anti-GM-CSF Monoclonal Antibody TJM2 in China On November 14, I-Mab Biopharma, a China and U.S.-based clinical-stage …
Read More
（20191027-1102） Amgen Purchases 20.5% stake in Chinese biotech BeiGene for USD $2.7 billion American leading multinational biopharmaceutical company Amgen and BeiGene, a Chinese immuno-oncology biopharmaceutical company, announced on Oct. 31 …
Read More
H. Spectrum and Merck to Launch Innovation Lab in Taipei. YongLin Health Foundation, which focuses on cultivating Taiwan’s biomedical talents and leading brands, and Merck, the world’s leading science and …
Read More
Bioatla and Beigene Collaborates to Develop and Commercialize Novel Conditionally Active Biologics BioAtla, LLC and BeiGene have entered into a global co-development and collaboration agreement for the development, manufacturing and …
Read More
Natera and BGI Genomics Announced Partnership to Commercialize Molecular Diagnostics in China The molecular diagnostics markets in China are rapidly growing, which driven by the rising incidence of cancer and …
Read More